These results suggest that PDIA3 may modulate cervical cancer occurrence and progression by affecting the six most critical types of immune cells: B cell memory, T cell regulatory, monocytes, macrophages M2, NK cell activated, and mast cells activated. This evidence concerns the gene PDIA3 and cervical carcinoma.